Skip to main content
. 2021 Jul 13;12:689663. doi: 10.3389/fimmu.2021.689663

Figure 3.

Figure 3

Plasma concentrations of Angiopoietin-2 (A) and ICAM-1 (B) at enrollment in healthy volunteers (Normal) and 29 corticosteroid resistant ITP patients who received consecutive low-dose decitabine therapy, including 15 responders (R) and 14 non-responders (NR).